about
Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screeningSmall-molecule inhibitors of dengue-virus entryOpen drug discovery for the Zika virusFlaviviruses: braking the enteringFlavivirus cell entry and membrane fusionCarbohydrate-related inhibitors of dengue virus entryIllustrating and homology modeling the proteins of the Zika virus.Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion IntermediateSolution structure of FK506-binding protein 12 from Aedes aegyptiIntrinsically Disordered Side of the Zika Virus ProteomeDengue virus ensures its fusion in late endosomes using compartment-specific lipids.Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical applicationSuppressing dengue-2 infection by chemical inhibition of Aedes aegypti host factors.Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric poreBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondProgress in the identification of dengue virus entry/fusion inhibitorsNovel approaches to flavivirus drug discovery.A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitroFunctional analysis of two cavities in flavivirus NS5 polymeraseThe bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replicationThe C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry.The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entryScreening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.A novel inhibitor of dengue virus replication that targets the capsid proteinWest Nile virus drug discovery.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Peptide inhibitors against dengue virus infection.Identification of a small-molecule inhibitor of dengue virus using a replicon system.An investigation of phenylthiazole antiflaviviral agents.Strategies for the treatment of dengue virus infections: a narrative account.GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein.Molecular Docking and Molecular Dynamics Simulation Studies to Predict Flavonoid Binding on the Surface of DENV2 E Protein.New pockets in dengue virus 2 surface identified by molecular dynamics simulation.Dengue virus entry as target for antiviral therapy.Halogenated Chrysins Inhibit Dengue and Zika Virus Infectivity.Surface supercharged human enteropeptidase light chain shows improved solubility and refolding yield.Peptides as Therapeutic Agents for Dengue Virus.Modulation of Lipid Droplet Metabolism-A Potential Target for Therapeutic Intervention in Flaviviridae Infections.Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein
P2860
Q22337991-804C038A-4D3E-4480-8F6B-5ABEEFD0DD5EQ22583513-116357B8-AE86-4551-A24B-2DAEE9643CC0Q22676298-829C82F0-0260-4931-8B3A-5F0269E823C9Q26852435-EE370105-B9BF-4EE5-B3D0-B3D1DCBDD68DQ26852458-E21948B0-91B1-4621-AA69-C5B103B02226Q26864413-6E5183F4-772B-4FB6-80BE-5865450BC8B7Q27313484-256068EB-A181-4A03-AB3D-D443791823D9Q27491339-D70C24E1-150F-46DF-ADB4-6395AA366871Q27681771-F3865D2C-D635-4AD4-820E-E2E108B8DD7DQ27926249-F1ED1BAC-5C9C-47FF-B6DF-B8411A028F89Q28475709-102EF56C-656C-4C5D-AF23-6EF672856224Q28486916-960271F2-37AE-4FBD-A796-1B6E84064DFBQ28541701-4B8C6D5B-87E4-423C-99E3-407D781450D2Q28541727-751D990F-DE65-42CD-A26F-5475140BE168Q29994527-80DE1E94-471C-49F3-9599-D80967D47EF9Q34054616-C74A84E0-D1EA-4D78-9A95-B6809B8DFB30Q34206832-4E6D325B-8154-403D-9634-6F4AC5F1DB82Q34309568-341092D7-C39A-40DD-8C3B-6D42E479DEC2Q34800273-2436E77B-C355-47EC-8554-2E36925C041EQ34923354-8EE6A3B8-70FA-4E74-945A-D3A0F1E513A9Q35000217-BBE3B941-FF19-47A6-9FFD-49B54118EFD3Q35076656-B566FCAD-D278-4F4A-AF45-7404859B41A6Q35855216-1A15EA0C-C9FD-44F4-A383-3550678A740AQ36505563-0E48BE13-71A9-497F-A84B-239750AF98B2Q37666750-76875EFD-8064-4A2B-A001-BD11D216CBCCQ38866173-76FD7041-C63D-4668-9D80-DBAFA5F2D61AQ39017020-2ED05AB8-C230-46EF-B989-790B3929C652Q39081733-9FA878AB-4EFE-4DC0-90E6-D456B7A0A1F0Q39536554-005BA42F-146A-4528-A632-9EC56B001261Q39769368-2202A2F8-CB8F-4754-8E68-316F8FF7E3A8Q40108772-E1467771-80F1-42DF-A4EC-763B15396C25Q40114331-53EF3EAD-5439-486A-9220-B8891472BAACQ40266244-056F54D8-BF03-43EE-90F4-5501EBEBE38CQ40289267-823F539D-8A94-4547-9116-51E6D245A15AQ42652891-7A4CA165-263F-470A-A11D-314FB0637B4AQ45171879-28991171-B16D-4539-B516-C42C842D8F7EQ45323856-C98475BC-4A94-4987-B2A2-DDB1DD0CAD4AQ47104952-A7020623-C28E-42D1-9B41-6F39DE593085Q56339834-67816D64-486A-4C8D-AAB0-B35FA1DE8203
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A small molecule fusion inhibitor of dengue virus
@ast
A small molecule fusion inhibitor of dengue virus
@en
A small molecule fusion inhibitor of dengue virus
@en-gb
A small molecule fusion inhibitor of dengue virus
@nl
type
label
A small molecule fusion inhibitor of dengue virus
@ast
A small molecule fusion inhibitor of dengue virus
@en
A small molecule fusion inhibitor of dengue virus
@en-gb
A small molecule fusion inhibitor of dengue virus
@nl
prefLabel
A small molecule fusion inhibitor of dengue virus
@ast
A small molecule fusion inhibitor of dengue virus
@en
A small molecule fusion inhibitor of dengue virus
@en-gb
A small molecule fusion inhibitor of dengue virus
@nl
P2093
P50
P3181
P1433
P1476
A small molecule fusion inhibitor of dengue virus
@en
P2093
John P Priestle
Jolanda M Smit
Markus R Wenk
Mee Kian Poh
Ngai Ling Ma
Wouter Schul
P3181
P356
10.1016/J.ANTIVIRAL.2009.09.011
P407
P577
2009-12-01T00:00:00Z